MONDAY, April 5, 2021 — Infants born by cesarean section initially have less diverse gut bacteria than those delivered vaginally, but they catch up within a few years, new research reveals.
The researchers also found that it takes a long time for these bacteria colonies — known as the gut microbiome — to mature.
“Our findings show that the gut microbiota is a dynamic organ, and future studies will have to show whether the early differences can affect the cesarean children later in life,” said study leader Fredrik Bäckhed. He’s a professor of molecular medicine at the University of Gothenburg in Sweden.
For the study, his team took fecal samples from 471 newborns, and again when they were 4 months, 12 months, 3 years and 5 years old. The samples were analyzed for gut bacteria.
It was already known that at birth, an infant’s intestine has already been colonized by bacteria and other microorganisms, and that the diversity of those species increases in the first few years of life.
This study provides more detailed information about development of the gut microbiome.
A key finding: Even at 5 years of age, it’s incomplete.
How long it takes for the gut microbiome to mature differs from child to child, and this study found that babies delivered by C-section initially had less diverse gut bacteria than infants delivered vaginally.
But by the time they reached 3 to 5 years of age, the diversity of gut bacteria was similar in both groups, according to findings published online March 31 in the journal Cell Host & Microbe.
“It’s striking that even at the age of 5 years, several of the bacteria that are important components of the intestinal microbiota in adults are missing in the children,” Bäckhed said in a university news release.
That shows that the intestine is a complex and dynamic environment where bacteria create conditions for colonization by one another, he added.
“By investigating and understanding how the intestinal microbiota develops in healthy children, we may get a reference point to explore if the microbiota may contribute to disease in future studies,” Bäckhed said.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
- South African regulator rejects Russia’s COVID-19 vaccine - October 20, 2021
- Second wave of pandemic not receded yet, third wave feared post-Diwali: Maha health minister - October 20, 2021
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya - October 20, 2021
- Trivitron Healthcare in collaboration with Diagon- Vanguard Diagnostics launches Diagon’s Coagulation range in India - October 20, 2021
- Breast cancer early detection, screening, and management – what we need to know - October 20, 2021
- WHO’s technical advisory group to meet on Oct 26 to consider Covaxin - October 19, 2021
- 163 oxygen plants set up in MP after shortage during 2nd COVID-19 wave: CM Shivraj Singh Chouhan - October 19, 2021
- India’s R-value below 1 since September, researchers say - October 19, 2021
- Mumbai: Double vaccine jab not mandatory to enter theatres, colleges to reopen with 50% attendance - October 19, 2021
- Daily exercise routine, balanced diet, active lifestyle & quality sleep key to success in personal & professional lives: Experts - October 19, 2021